Silence Therapeutics reported $57.19M in Cash and Equivalent for its fiscal quarter ending in June of 2025.





Cash And Equivalent Change Date
AstraZeneca USD 4.89B 2.67B Jun/2026
Autolus Therapeutics Ltd USD 171.41M 40.49M Jun/2026
Hikma Pharmaceutical USD 217M 19M Dec/2025
Novartis USD 7.62B 739M Jun/2026
Roche Holding CHF 7.55B 579M Jun/2025
Silence Therapeutics USD 57.19M 4.77M Jun/2025